La bourse ferme dans 8 h 20 min

Alcon Inc. (ALC)

NYSE - NYSE Prix différé. Devise en USD
Ajouter à la liste dynamique
80,35-0,62 (-0,77 %)
À la clôture : 04:00PM EDT
80,00 -0,35 (-0,44 %)
Échanges après Bourse : 05:16PM EDT

Alcon Inc.

Chemin de Blandonnet 8
Vernier
Geneva 1214
Switzerland
41 589 112 110
https://www.alcon.com

Secteur(s)Healthcare
Secteur d’activitéMedical Instruments & Supplies
Employés à temps plein25 315

Dirigeants clés

NomTitrePayerExercéAnnée de naissance
Mr. F. Michael BallExecutive Chairman1,17MS.O.1955
Mr. Timothy C. StonesiferChief Financial OfficerS.O.S.O.1967
Margaret BuckleyChief Accounting OfficerS.O.S.O.S.O.
Dr. Franck LeveillerSenior VP, Head of Global R&D and Chief Scientific OfficerS.O.S.O.S.O.
Ms. Sue-Jean LinSenior VP and Chief Information & Transformation OfficerS.O.S.O.1959
Mr. Royce R. BedwardSenior VP, General Counsel & Corporate SecretaryS.O.S.O.1966
Ms. Kimberly MartinSenior VP, Chief HR Officer & Corporate CommunicationsS.O.S.O.1975
Mr. Laurent AttiasHead of Corporate Development, Strategy, BD&L and M&AS.O.S.O.1968
Mr. Leon Sergio Duplan FraustroPresident of North AmericaS.O.S.O.1968
Mr. Ed McGoughSenior VP and Head of Global Manufacturing & Technical Operations1,02M1,54M1961
Les montants ont été établis en date du 31 décembre 2023 et les valeurs de compensation concernent le dernier exercice fiscal clos à cette date. Le terme « rémunération » désigne le salaire, les bonus, etc. Le terme « exercé » est utilisé pour la valeur des options exercées au cours de l’exercice fiscal. Devise exprimée en USD.

Description

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. Its cataract products include Centurion vision system, LenSx laser system, ARGOS biometer, LuxOR surgical ophthalmic microscope, SMARTCATARACT health platform, NGENUITY 3D visualization system, Verion reference unit and Verion digital marker, and ORA system for intra-operative measurements; custom pak surgical procedure packs; vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, and grieshaber and MIVS instruments, as well as scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; refractive surgery products, including WaveLight lasers and Contoura Vision used for LASIK treatment; EX-PRESS glaucoma filtration device; and implantable products, including AcrySof IQ products, such as monofocal IOLs and advanced technology IOLs for the correction of presbyopia and astigmatism at the time of cataract surgery. Its Vision Care segment provides daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, glaucoma, contact lens care, and ocular allergies; and ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.

Gouvernance d’entreprise

L’ISS Governance QualityScore de Alcon Inc. en date du 1 mai 2024 est 5. Les scores principaux sont Audit : 1; Société : 3; Droits des actionnaires : 1; Compensation : 7.

Résultats de gouvernance d’entreprise offerts par Institutional Shareholder Services (ISS). Les résultats indiquent un rang décile par rapport à l’indice ou à la région. Un résultat décile de 1 indique un risque de gouvernance faible, tandis que 10 indique un risque de gouvernance élevé.